Low-income individuals and communities of color, already besieged by poor access to health care, limited insurance coverage, and other health inequities exposed by COVID-19, also suffer another health disparity – they are among the hardest hit by continually rising prescription drug prices. Since 2017, states across the nation have taken action to lower rising drug […]
Author Archive for: aattiya
About Amanda Attiya
Amanda Attiya is a research analyst with NASHP’s Emerging Policy Issues team. Prior to joining NASHP in June 2020, Attiya worked as an intern with the House Committee on Ways and Means, where she provided assistance to the Subcommittee on Health’s project on improving the quality of health services in rural and underserved regions. She also interned for US Sen. Tim Kaine (VA) and US Rep. Jeff Van Drew (NJ) where she conducted extensive legislative research. She now works on several NASHP projects addressing drug pricing and patient-centered outcomes research. Attiya graduated from George Mason University in 2020, where she was awarded a BS in public administration with a minor in health and social policy.
Entries by Amanda Attiya
In response to COVID-19, states have made swift and unprecedented changes to enable the use of telehealth to meet the public’s need to safely access care remotely. Now, policymakers face the challenge of analyzing whether to sustain these changes as they weigh cost, privacy, and security considerations and effectiveness of remote care delivery. As officials […]
A 2016 New Jersey law gave the state flexibility to share bid information submitted by all pharmacy benefit managers (PBMs) in order to incentivize the PBMs to submit lower offers in additional rounds of bidding – a process known as a reverse auction. While reverse auctions have been used historically to procure goods, New Jersey’s […]